Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/30/2025 | $150.00 | Overweight | Piper Sandler |
| 5/14/2025 | $150.00 | Equal-Weight → Overweight | Morgan Stanley |
| 4/15/2025 | $119.00 | Hold → Buy | HSBC Securities |
| 3/20/2025 | $150.00 → $141.00 | Equal Weight → Overweight | Wells Fargo |
| 1/30/2025 | $173.00 | Buy → Hold | HSBC Securities |
| 9/18/2024 | $148.00 | Buy | HSBC Securities |
| 9/12/2024 | $130.00 | Equal Weight | Wells Fargo |
| 8/27/2024 | $153.00 | Buy | Redburn Atlantic |
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Issuer)
Acquisition to be followed by merger; strengthens Torrent's IPM market presence Torrent Pharmaceuticals Limited ("Torrent") and global investment firm KKR today announced that Torrent has entered into definitive agreements to acquire controlling stake in J. B. Chemicals and Pharmaceuticals ("JB Pharma") from KKR at an Equity Valuation of INR 25,689 crores (on fully diluted basis), followed by a merger of the two entities. The transaction marks a significant step in Torrent's ambition to create a future-ready, diversified healthcare platform combining a deep chronic segment heritage with emerging international CDMO capabilities. This press release features multimedia. View the full releas
KKR today announced a monetization activity update for the period from April 1, 2025 to June 20, 2025. Based on information available to us as of today, with respect to the period through June 20, 2025, KKR's Asset Management segment has earned total realized performance income and total realized investment income in excess of $475 million. This amount includes performance income that is expected to be crystallized at June 30, 2025.(1) The monetization activity quarter-to-date in second quarter 2025 is made up of approximately 75% realized performance income and approximately 25% realized investment income. The quarter-to-date monetization activity is driven by a combination of public secon
KKR Income Opportunities Fund (the "Fund") (NYSE:KIO) today announced its monthly distributions of $0.1215 per common share, payable on the dates below. Based on the Fund's current share price of $12.27 per share (as of market close on June 16, 2025), the distributions represent an annualized distribution rate of 11.88%, (calculated by annualizing the distribution amount and dividing it by the current price). The monthly distribution schedule is as follows for the months of July, August, and September: Ex-Date: July 11, 2025 Record Date: July 11, 2025 Payable Date: July 31, 2025 Ex-Date: August 8, 2025 Record Date: August 8, 2025 Payable Date: August 29, 2025 Ex-Date: September 12,
8-K - KKR & Co. Inc. (0001404912) (Filer)
144 - KKR & Co. Inc. (0001404912) (Subject)
144 - KKR & Co. Inc. (0001404912) (Subject)